Novel technologies for applying immune checkpoint blockers

Zoekresultaten

• Afgelopen

  FWOSB81: Versterken van de functie van kanker tegenwerkende effector cellen met behulp van nanobodies specifiek voor regulerende immuun controle punten

  Breckpot, K., Devoogdt, N., Keyaerts, M. & Awad, R. M.

  1/11/19 → 31/10/23

  Project: Fundamenteel

  • Single-Domain Antibodies 100%
  • Monoclonal Antibodies 21%
  • Neoplasms 20%
  • avelumab 17%
  • Ligands 12%

• FWOAL934: Slim ontwerp van nanoPartikels om AfweerReacties tegen Kanker te activeren (SPARK)

  Breckpot, K., Keyaerts, M., Barbé, K. & De Smedt, S.

  1/01/19 → 31/12/22

  Project: Fundamenteel

  • Single-Domain Antibodies 100%
  • Natural Killer T-Cells 40%
  • Vaccination 37%
  • Messenger RNA 34%
  • Neoplasms 33%

• AIIFUND14: Development of navel anti-checkpoint strategies based on nanobodies.

  Breckpot, K., Devoogdt, N. & Keyaerts, M.

  15/05/17 → 14/05/21

  Project: Fundamenteel

  • Single-Domain Antibodies 100%
  • Annual Reports 46%
  • Monoclonal Antibodies 30%
  • avelumab 29%
  • Technology 22%

• ANI144: NICHE: Nanobody-mediated Immune CHEckpoint imaging and inhibition

  Breckpot, K., Thielemans, K. & Devoogdt, N.

  1/10/15 → 30/09/21

  Project: Fundamenteel

  • Single-Domain Antibodies 100%
  • Neoplasms 22%
  • Ligands 15%
  • Theranostic Nanomedicine 14%
  • Immunotherapy 12%